Jason Barrow v. HHS - Tdap, Guillain-Barre Syndrome (GBS) (2021)
Case summary [AI summaries can sometimes make mistakes]
Jason Barrow filed a petition for compensation under the National Vaccine Injury Compensation Program on August 24, 2021, alleging that he suffered Guillain-Barre Syndrome (GBS) as a result of his tetanus-diphtheria-acellular pertussis (Tdap) vaccination on June 11, 2019. Mr.
Barrow stated that he experienced residual effects of his alleged injury for longer than six months and had not previously received compensation for a vaccine-related injury. The respondent denied that the Tdap vaccine caused Mr.
Barrow's GBS or any other injury. Despite the respondent's denial, the parties filed a joint stipulation on August 24, 2021, agreeing that compensation should be awarded.
Special Master Daniel T. Horner found the stipulation reasonable and adopted it as the decision of the Court.
Mr. Barrow was awarded a lump sum of $130,315.74, payable to him by check.
This amount represents compensation for all items of damages available under the Vaccine Act. The decision was issued on September 21, 2021.
Petitioner counsel was Leah VaSahnja Durant and respondent counsel was Mollie Danielle Gorney.
Theory of causation
Petitioner Jason Barrow alleged that his June 11, 2019, Tdap vaccination caused Guillain-Barre Syndrome (GBS). Respondent denied causation. The parties filed a joint stipulation agreeing to an award. The public decision does not describe the specific theory of causation, medical experts, clinical details of the injury, onset, symptoms, diagnostic tests, or treatments. Special Master Daniel T. Horner adopted the stipulation, awarding $130,315.74 as compensation for all damages under the Vaccine Act. The decision was issued on September 21, 2021. Petitioner was represented by Leah VaSahnja Durant and respondent by Mollie Danielle Gorney.
Source PDFs
USCOURTS-cofc-1_20-vv-00915